Floatz logo

38 assets in Neoplastic Meningitis

Therapeutic assets addressing Neoplastic Meningitis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cytarabine
Neoplastic Meningitis
Fudan UniversityP4BBB (72)
Dexasone
Neoplastic Meningitis
Shanghai Cancer Hospital, ChinaP2B (63)
Lorlatinib
Neoplastic Meningitis
Guangdong Association of Clinical TrialsP4B (62)
Cis-Diamminedichloroplatinum Ii
Neoplastic Meningitis
Guangzhou Medical UniversityP2B (61)
Etoposide
Neoplastic Meningitis
Guangzhou Medical UniversityP2B (61)
Methotrexate
Neoplastic Meningitis
The First Affiliated Hospital with Nanjing Medical UniversityP4B (61)
Cyclophosphamide
Neoplastic Meningitis
Medical College of WisconsinP2B (60)
Paclitaxel Trevatide
Neoplastic Meningitis
Angiochem IncP3B (60)
Nivolumab
Neoplastic Meningitis
Shanghai Cancer Hospital, ChinaP2B (58)
Pembrolizumab
Neoplastic Meningitis
Medical College of WisconsinP2B (58)
Trastuzumab
Neoplastic Meningitis
UNICANCERP2B (58)
Osimertinib
Neoplastic Meningitis
Second Affiliated Hospital of Nanchang UniversityP2B (57)
Thiotepa
Neoplastic Meningitis
The First Affiliated Hospital with Nanjing Medical UniversityP2B (57)
Trastuzumab Deruxtecan
Neoplastic Meningitis
Memorial Sloan Kettering Cancer CenterP2B (57)
ty-9591
Neoplastic Meningitis
TYK Medicines, IncP2B (57)
Capecitabine
Neoplastic Meningitis
UNICANCERP2CCC (53)
qbs72s
Neoplastic Meningitis
Stanford UniversityP2CCC (53)
Tucatinib
Neoplastic Meningitis
UNICANCERP2CCC (53)
Zorifertinib
Neoplastic Meningitis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2CCC (53)
Biottt001
Neoplastic Meningitis
Henan Cancer HospitalP1/2CCC (48)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
Neoplastic Meningitis
Peking University Cancer Hospital & InstituteP1/2CC (45)
Omburtamab
Neoplastic Meningitis
Y-mAbs TherapeuticsP1/2CC (45)
Pertuzumab
Neoplastic Meningitis
H. Lee Moffitt Cancer Center and Research InstituteP1/2CC (45)
Toripalimab
Neoplastic Meningitis
Guangzhou Medical UniversityP1/2CC (45)
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells
Neoplastic Meningitis
City of Hope Medical CenterP1CC (43)
Vinorelbine Ditartrate
Neoplastic Meningitis
Northwestern UniversityP1CC (43)
Azeliragon
Neoplastic Meningitis
NYU Langone HealthP1CC (41)
Ipilimumab
Neoplastic Meningitis
University of ZurichP1CC (41)
Paxalisib
Neoplastic Meningitis
Memorial Sloan Kettering Cancer CenterP1CC (41)
Rhenium (¹??Re) Obisbemeda
Neoplastic Meningitis
Plus TherapeuticsP1CC (41)
Sv-Br-1-Gm
Neoplastic Meningitis
Medical College of WisconsinP1CC (41)
qh101 cell
Neoplastic Meningitis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
Famitinib
Neoplastic Meningitis
Second Affiliated Hospital of Nanchang UniversityN/AD (30)
Ivonescimab
Neoplastic Meningitis
Jiangsu Province Nanjing Brain HospitalN/AD (30)
qh104 cell
Neoplastic Meningitis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/AD (30)
Trotabresib
Neoplastic Meningitis
Northwestern UniversityP1D (23)
azd1390
Neoplastic Meningitis
AstraZenecaP1NR ()
Vometinib
Neoplastic Meningitis
Zhejiang Cancer HospitalP2NR ()